In-vitro drug release studies of rifampicin
nanoparticles
An initial burst release 20% in 4 hours due to the surface-associated
drug as part of the biphasic release profile. Complete release was
observed in SIF, while only a 65 percent release was identified in SGF.
(Fig- 2).